InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

ARTIVION, INC.

AORT Clue Score41
United States Fiscal year ends December CIK 0000784199 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
Andrew M Green
10 Sep 2026
SVP, Regulatory and Quality
Sell
11,480
$24.97
$286.66K
Andrew M Green
3 Sep 2026
SVP, Regulatory and Quality
Sell
1,493
$26.02
$38.84K
Andrew M Green
2 Sep 2026
SVP, Regulatory and Quality
Sell
6,510
$27.27
$177.50K
James P Mackin
19 Aug 2026
President & CEO
Sell
70,000
$28.96
$2.03M
Lance A Berry
14 Aug 2026
EVP, COO, CFO & Treasurer
Sell
715
$28.55
$20.41K
Andrew M Green
14 Aug 2026
SVP, Regulatory and Quality
Sell
616
$28.55
$17.59K
Jean F Holloway
12 Aug 2026
SVP, General Counsel
Sell
977
$28.49
$27.83K
Jean F Holloway
4 Mar 2026
SVP, General Counsel
Sell
8,962
$38.00
$340.56K
James P Mackin
3 Mar 2026
President & CEO
Sell
17,887
$37.78
$675.69K
Lance A Berry
3 Mar 2026
EVP, COO, CFO & Treasurer
Sell
6,316
$37.78
$238.59K
John E Davis
3 Mar 2026
Chief Commercial Officer
Sell
4,573
$37.78
$172.75K
Marshall S. Stanton
3 Mar 2026
SVP, Clinical & MD Affair
Sell
2,149
$37.78
$81.18K
Jean F Holloway
3 Mar 2026
SVP, General Counsel
Sell
3,843
$37.78
$145.17K
Amy Horton
3 Mar 2026
VP, Chief Accounting Officer
Sell
901
$37.78
$34.04K
John E Davis
2 Mar 2026
Chief Commercial Officer
Sell
2,784
$38.02
$105.86K
Lance A Berry
2 Mar 2026
EVP, COO, CFO & Treasurer
Sell
5,178
$38.02
$196.89K
Jean F Holloway
2 Mar 2026
SVP, General Counsel
Sell
2,183
$38.02
$83.01K
James P Mackin
2 Mar 2026
President & CEO
Sell
14,911
$38.02
$566.99K
Marshall S. Stanton
2 Mar 2026
SVP, Clinical & MD Affair
Sell
1,513
$38.02
$57.53K
Amy Horton
2 Mar 2026
VP, Chief Accounting Officer
Sell
641
$38.02
$24.37K
John E Davis
24 Feb 2026
Chief Commercial Officer
Sell
2,075
$35.69
$74.06K
Lance A Berry
24 Feb 2026
EVP, COO, CFO & Treasurer
Sell
4,485
$35.69
$160.08K
James P Mackin
24 Feb 2026
President & CEO
Sell
13,936
$35.69
$497.42K
Jean F Holloway
24 Feb 2026
SVP, General Counsel
Sell
1,668
$35.69
$59.54K
Marshall S. Stanton
24 Feb 2026
SVP, Clinical & MD Affair
Sell
1,259
$35.69
$44.94K
Amy Horton
24 Feb 2026
VP, Chief Accounting Officer
Sell
830
$35.69
$29.63K
John E Davis
23 Feb 2026
Chief Commercial Officer
Sell
3,773
$37.59
$141.82K
Lance A Berry
23 Feb 2026
EVP, COO, CFO & Treasurer
Sell
4,981
$37.59
$187.23K
James P Mackin
23 Feb 2026
President & CEO
Sell
20,962
$37.59
$787.92K
Jean F Holloway
23 Feb 2026
SVP, General Counsel
Sell
3,079
$37.59
$115.73K
Marshall S. Stanton
23 Feb 2026
SVP, Clinical & MD Affair
Sell
2,423
$37.59
$91.08K
Amy Horton
23 Feb 2026
VP, Chief Accounting Officer
Sell
1,731
$37.59
$65.06K
John E Davis
15 Dec 2025
Chief Commercial Officer
Sell
5,000
$45.11
$225.55K
Amy Horton
8 Dec 2025
VP, Chief Accounting Officer
Sell
4,572
$44.42
$203.08K
Jean F Holloway
3 Dec 2025
SVP, General Counsel
Sell
5,267
$45.30
$238.60K
Jean F Holloway
3 Dec 2025
SVP, General Counsel
Sell
2,048
$45.30
$92.77K
Elizabeth A Hoff
18 Nov 2025
Director
Sell
4,200
$45.10
$189.41K
Amy Horton
17 Nov 2025
VP, Chief Accounting Officer
Sell
6,000
$45.73
$274.38K
Marshall S. Stanton
13 Nov 2025
SVP, Clinical & MD Affair
Sell
4,993
$45.86
$228.97K
Jean F Holloway
13 Nov 2025
SVP, General Counsel
Sell
5,761
$45.86
$264.19K
James P Mackin
13 Nov 2025
President & CEO
Sell
34,210
$45.86
$1.57M
John E Davis
13 Nov 2025
Chief Commercial Officer
Sell
6,563
$45.86
$300.97K
Amy Horton
13 Nov 2025
VP, Chief Accounting Officer
Sell
3,482
$45.86
$159.68K
Marshall S. Stanton
10 Nov 2025
SVP, Clinical & MD Affair
Sell
2,566
$44.62
$114.49K
Amy Horton
10 Nov 2025
VP, Chief Accounting Officer
Sell
1,789
$44.62
$79.82K
John E Davis
10 Nov 2025
Chief Commercial Officer
Sell
3,373
$44.62
$150.50K
James P Mackin
10 Nov 2025
President & CEO
Sell
17,580
$44.62
$784.40K
Jean F Holloway
10 Nov 2025
SVP, General Counsel
Sell
2,960
$44.62
$132.07K
Show all 64 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 16
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 690,931
History held since 12 Oct 2006